ME3
NADP-dependent malic enzyme, mitochondrial
Also known as: MAON_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16798
- Gene
- ME3
- Ensembl
- ENSG00000151376
- Chromosome
- 11
- Canonical length
- 604 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
OverviewNCBI Gene
Malic enzyme catalyzes the oxidative decarboxylation of malate to pyruvate using either NAD+ or NADP+ as a cofactor. Mammalian tissues contain 3 distinct isoforms of malic enzyme: a cytosolic NADP(+)-dependent isoform, a mitochondrial NADP(+)-dependent isoform, and a mitochondrial NAD(+)-dependent isoform. This gene encodes a mitochondrial NADP(+)-dependent isoform. Multiple alternatively spliced transcript variants have been found for this gene, but the biological validity of some variants has not been determined. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
604 residues, UniProt reviewed canonical sequence.
>Q16798|ME3
1 MGAALGTGTR LAPWPGRACG ALPRWTPTAP AQGCHSKPGP ARPVPLKKRG YDVTRNPHLN
61 KGMAFTLEER LQLGIHGLIP PCFLSQDVQL LRIMRYYERQ QSDLDKYIIL MTLQDRNEKL
121 FYRVLTSDVE KFMPIVYTPT VGLACQHYGL TFRRPRGLFI TIHDKGHLAT MLNSWPEDNI
181 KAVVVTDGER ILGLGDLGCY GMGIPVGKLA LYTACGGVNP QQCLPVLLDV GTNNEELLRD
241 PLYIGLKHQR VHGKAYDDLL DEFMQAVTDK FGINCLIQFE DFANANAFRL LNKYRNKYCM
301 FNDDIQGTAS VAVAGILAAL RITKNKLSNH VFVFQGAGEA AMGIAHLLVM ALEKEGVPKA
361 EATRKIWMVD SKGLIVKGRS HLNHEKEMFA QDHPEVNSLE EVVRLVKPTA IIGVAAIAGA
421 FTEQILRDMA SFHERPIIFA LSNPTSKAEC TAEKCYRVTE GRGIFASGSP FKSVTLEDGK
481 TFIPGQGNNA YVFPGVALGV IAGGIRHIPD EIFLLTAEQI AQEVSEQHLS QGRLYPPLST
541 IRDVSLRIAI KVLDYAYKHN LASYYPEPKD KEAFVRSLVY TPDYDSFTLD SYTWPKEAMN
601 VQTVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ME3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- ovary: 29 nTPM
- basal ganglia: 28 nTPM
- heart muscle: 27 nTPM
- cervix: 26 nTPM
- kidney: 26 nTPM
- adrenal gland: 25 nTPM
Single-cell type
- distal convoluted tubule cells: 390 nCPM
- brain inhibitory neurons: 217 nCPM
- retinal horizontal cells: 208 nCPM
- cardiomyocytes: 202 nCPM
- gonadotrophs: 200 nCPM
- renal connecting tubule cells: 163 nCPM
Immune cell
- myeloid DC: 2.2 nTPM
- memory CD8 T-cell: 1.2 nTPM
- naive CD8 T-cell: 1.1 nTPM
- NK-cell: 1 nTPM
- naive CD4 T-cell: 0.9 nTPM
- gdT-cell: 0.7 nTPM
Brain region
- cerebral cortex: 94 nTPM
- midbrain: 88 nTPM
- basal ganglia: 83 nTPM
- pons: 83 nTPM
- thalamus: 74 nTPM
- amygdala: 72 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.07
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.33
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- malate dehydrogenase (decarboxylating) (NADP+) activity
- malic enzyme activity
- metal ion binding
- NAD binding
- NADP+ binding
- oxaloacetate decarboxylase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Malic oxidoreductase
- Malic enzyme, N-terminal domain
- Malic enzyme, NAD-binding
- Malic enzyme, conserved site
- NAD(P)-binding domain superfamily
- Malic enzyme, N-terminal domain superfamily
- Aminoacid dehydrogenase-like, N-terminal domain superfamily
- Malic enzyme, N-terminal domain
- Malic enzyme, NAD binding domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ME3 as an antibody target. Whether an autoantibody or antibody against ME3 could matter depends on whether native ME3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ME3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ME3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...